Top Harvest Capital

Youlify is a company that specializes in AI-driven solutions for medical billing and revenue cycle management. Its platform is designed to assist medical practices in improving their billing and collections processes by offering an AI-powered onboarding approach that enhances payment efficiency. Additionally, Youlify provides tools for investigating denied claims and delivers real-time financial insights and analytics. This enables healthcare providers to appeal denied claims effectively, increasing their chances of successful resolution. Overall, Youlify focuses on leveraging artificial intelligence to optimize financial operations within the medical sector.

Voxel51, Inc. is an AI software company based in Ann Arbor, Michigan, founded in 2016. The company specializes in computer vision and machine learning analytics, focusing on the understanding of video and image data. Voxel51's technology transforms raw video footage and images into actionable intelligence, utilizing machine learning to process and label content based on image recognition and the analysis of motions and objects over time. This enables data scientists in the field of computer vision to efficiently curate, explore, and test datasets alongside their models, facilitating the development of production-ready visual AI solutions.

Leash Biosciences engages in machine learning to solve medicinal chemistry.

Bioptimus is a biotechnology company focused on developing a universal artificial intelligence foundation model that integrates various scales of biology, from molecules to cells, tissues, and entire organisms. The company's innovative technology leverages generative AI to transform complex multiscale biological data into actionable insights, facilitating significant advancements in scientific research and biomedical innovation. By enabling clients to effectively harness this data, Bioptimus aims to drive breakthrough discoveries and enhance the efficiency of biotechnological processes.

Vectara is a developer of a generative AI product platform that enables businesses to integrate advanced AI features into their applications. The company offers an end-to-end serverless Retrieval Augmented Generation (RAG) API platform, which provides a secure and efficient way to incorporate conversational AI and question-answering capabilities. Vectara's platform is built on a hybrid-search core, ensuring accurate and reliable results that are grounded in the specific data and knowledge of the organization. It addresses critical challenges associated with enterprise adoption, such as reducing hallucination, enhancing explainability, enforcing access control, and allowing for real-time updates of knowledge. Additionally, Vectara's platform supports multilingual capabilities and prioritizes data security, making it suitable for various applications including semantic search, research analysis, and conversational AI, thus enabling organizations to create experiences similar to ChatGPT.

Inato provides an AI-powered platform that automates the collection, structuring, and analysis of data used to launch clinical trials for life sciences companies. Founded in 2016 and headquartered in Paris, with offices in New York and London, the company connects pharmaceutical developers with a global network of research sites through a clinical trial marketplace, facilitating enrollment planning and ongoing site support. By cross-checking data sources and deriving actionable insights, Inato aims to reduce drug development costs and shorten timelines, helping therapies reach patients faster and more efficiently.

Asaren manages the mental health needs of their blue-chip clients' employees, with industries ranging from banking, energy, retail, and many others. They provide triage assessment, DNA testing, and online consultation with medical professionals.

Rembrand is an advertising agency specializing in a comprehensive range of marketing services, including brand strategy, campaign management, and social media marketing. The company offers digital marketing solutions such as content marketing, newsletter, display advertising, and employer branding. Additionally, Rembrand has developed a programmatic product placement platform that utilizes generative AI to enhance videos with virtual product placements, allowing brands to connect seamlessly with creators to scale their marketing efforts. This innovative approach to monetizing videos without interruptive ads positions Rembrand as a forward-thinking player in the advertising landscape.

Vectara is a developer of a generative AI product platform that enables businesses to integrate advanced AI features into their applications. The company offers an end-to-end serverless Retrieval Augmented Generation (RAG) API platform, which provides a secure and efficient way to incorporate conversational AI and question-answering capabilities. Vectara's platform is built on a hybrid-search core, ensuring accurate and reliable results that are grounded in the specific data and knowledge of the organization. It addresses critical challenges associated with enterprise adoption, such as reducing hallucination, enhancing explainability, enforcing access control, and allowing for real-time updates of knowledge. Additionally, Vectara's platform supports multilingual capabilities and prioritizes data security, making it suitable for various applications including semantic search, research analysis, and conversational AI, thus enabling organizations to create experiences similar to ChatGPT.

Voxel51, Inc. is an AI software company based in Ann Arbor, Michigan, founded in 2016. The company specializes in computer vision and machine learning analytics, focusing on the understanding of video and image data. Voxel51's technology transforms raw video footage and images into actionable intelligence, utilizing machine learning to process and label content based on image recognition and the analysis of motions and objects over time. This enables data scientists in the field of computer vision to efficiently curate, explore, and test datasets alongside their models, facilitating the development of production-ready visual AI solutions.

Hedera Dx develops and commercializes liquid biopsy technology for hospital laboratories, enabling in-house clinically useful liquid biopsies that support tumor profiling and access to advanced diagnostic tools. The platform addresses regulatory compliance, privacy, and validation challenges and aims to simplify workflows that are currently inefficient. It offers early detection, therapy selection, and recurrence monitoring capabilities alongside aggregated clinical insights to help clinicians and researchers reduce cancer-related mortality and improve patient outcomes, while supporting drug development. Hedera Dx was founded on July 1, 2021 in Epalinges, Vaud.

Kinetix is a company founded in 2020 and based in Paris, France, that focuses on empowering self-expression in the Metaverse through artificial intelligence and no-code tools. It provides solutions that enable users to easily create 3D animations, making this technology accessible to a broader audience. Kinetix leverages advancements in AI to streamline the animation process, allowing individuals without technical expertise to engage in creative activities within virtual environments. Its mission centers on democratizing the creation of digital content, contributing to the evolving landscape of the Metaverse and enhancing the ways in which users can communicate and express themselves digitally.

Mindmesh is a software developer focused on enhancing communication and efficiency for product-oriented teams and managers. The company provides a knowledge base tool that addresses challenges related to context switching and information fragmentation. Its innovative interface centralizes actionable insights from various sources, including notes, tasks, and calendars, while integrating seamlessly with popular team collaboration tools such as Slack, Gmail, Calendar, Jira, and Drive. By facilitating the quick creation of concise documentation and enabling the search for dispersed knowledge, Mindmesh aims to foster collaboration among employees, allowing them to easily connect and access information regardless of their current tasks or locations.

MEDIC Life Sciences is a biotechnology company based in the San Francisco Bay Area, specializing in cancer drug discovery. The company utilizes a proprietary CRISPR functional genomics platform to develop synergistic drug combinations for cancer treatment. By employing advanced 3D tumor models, MEDIC accurately captures tumor suppressor and oncogene phenotypes, systematically integrating CRISPR variants that mimic cancer mutations. This innovative approach allows for comprehensive measurement of drug associations with various mutations, ultimately enabling healthcare companies to create effective therapeutic options for treating tumors and other related diseases.

Mantium is a secure cloud-based data platform that facilitates software developers in accessing, transforming, and enriching data using large language models while ensuring data privacy and security. The platform offers a no-code solution that streamlines workflows through automated data preparation, which includes capabilities for transforming, cleaning, and enriching data from diverse sources. By enabling the creation of various datasets and managing data pipelines and infrastructure, Mantium accelerates the artificial intelligence journey for its clients, effectively supporting them in the initial stages of the AI development process.

Hedera Dx develops and commercializes liquid biopsy technology for hospital laboratories, enabling in-house clinically useful liquid biopsies that support tumor profiling and access to advanced diagnostic tools. The platform addresses regulatory compliance, privacy, and validation challenges and aims to simplify workflows that are currently inefficient. It offers early detection, therapy selection, and recurrence monitoring capabilities alongside aggregated clinical insights to help clinicians and researchers reduce cancer-related mortality and improve patient outcomes, while supporting drug development. Hedera Dx was founded on July 1, 2021 in Epalinges, Vaud.